Pallisgaard, J. L., Lindhardt, T. B., Hansen, M. L., Schjerning, A., Olesen, J. B., Staerk, L., . . . Gislason, G. H. (2015). Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study. PLoS One.
Dyfyniad Arddull ChicagoPallisgaard, Jannik Langtved, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, and Gunnar Hilmar Gislason. "Cardioversion and Risk of Adverse Events With Dabigatran Versus Warfarin—A Nationwide Cohort Study." PLoS One 2015.
Dyfyniad MLAPallisgaard, Jannik Langtved, et al. "Cardioversion and Risk of Adverse Events With Dabigatran Versus Warfarin—A Nationwide Cohort Study." PLoS One 2015.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.